GSK
More News
-
GlaxoSmithKline to begin human trials for HIV cure
GSK is aiming to find a cure for HIV while also developing longer-acting drug treatments and preventive therapies.
-
GSK, CureVac team up to develop vaccine against Covid-19 variants
Both GSK & CureVac have teamed up in 150 million euro ($180 million) deal to develop a vaccine targeting new variants
-
The world will need more than one COVID-19 vaccine, GSK CEO says
Says partnership with Sanofi brings scale to the attempt to get a COVID-19 vaccine
-
Public and private researchers hunt coronavirus cure
Researchers are mainly working to develop diagnostic tests, vaccines and anti-virals
-
Big pharma turns to AI to speed drug discovery, GSK signs deal
Leading drug companies turning to artificial intelligence to improve hit-and-miss business of finding new medicines
-
Three countries to pilot world's first malaria vaccine
Malaria kills around 430,000 people a year, the vast majority of them babies and young children in sub-Saharan Africa
-
GSK Consumer Healthcare gets listed at PSX
Share price shoots to upper price limit after opening at Rs61.98 per share
